Clinical Trials · NCT03057509

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

WithdrawnPhase 1Octreotide (Prohibited)
Phase
Phase 1
Recruitment status
Withdrawn
Sponsor
Massachusetts General Hospital
Enrollment
0
Start date
Nov 2018
Locations
2 sites, United States
Primary endpoint
Mean Change in SUVmax
View Octreotide compound reference